PAD4 inhibition in neutrophils halts cancer progression and metastasis
Researchers in the laboratory of Yulia Nefedova, M.D., Ph.D., at The Wistar Institute and collaborators at Jubilant Therapeutics Inc. have uncovered a novel mechanism by which protein arginine deiminase 4 (PAD4) in neutrophils ...
Sep 7, 2022
0
23